HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.

AuthorsMary G Boy, Cunshan Wang, Bethanie E Wilkinson, Vincent Fung-Sing Chow, Alan T Clucas, James G Krueger, Anderson S Gaweco, Samuel H Zwillich, Paul S Changelian, Gary Chan
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 129 Issue 9 Pg. 2299-302 (Sep 2009) ISSN: 1523-1747 [Electronic] United States
PMID19225543 (Publication Type: Clinical Trial, Phase I, Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Piperidines
  • Pyrimidines
  • Pyrroles
  • tofacitinib
Topics
  • Adult
  • Biopsy
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Humans
  • Middle Aged
  • Piperidines
  • Psoriasis (drug therapy, immunology, pathology)
  • Pyrimidines (adverse effects, therapeutic use)
  • Pyrroles (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: